ARTICLE

ROLE OF BNP AND PROBNP AS PROGNOSTIC FACTORS IN PREDICTING THE MORTALITY OF PATIENTS OF CHRONIC HEART FAILURE CHF

  1. HOME
  2. ARTICLE

02 Pages : 10-16

http://dx.doi.org/10.31703/giidr.2019(IV-I).02      10.31703/giidr.2019(IV-I).02      Published : Dec 2019

Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF)

Abstract

    Diseases like heart failure is quite serious as the indications are not very clear to declare about its prognosis in the patient. This review depicts a study about the use of Btype natriuretic peptide levels to make an estimate about different heart functions. These calculations are very useful in the prognosis of heart diseases changes in functions of diastole. BNP and ANP are the natriuretic peptides that are reported to be raised in dysfunction of left ventricles. BNP and NT-proBNP are the markers whose levels can be observed in plasma serum are being used because of the available tests and assays on commercial scale. By the prognostic comparison study of NT-proBNP and BNP for the clinical diagnosis of HF disclosed that no statistical difference was found between them.

    Natriuretic Peptides, Prognostic Factors, B-Type Natriuretic Peptide, Heart Failure, CHF, Mortality Rate

    (1) Arooj Shahid
    Pharm-D, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
    (2) Muhammad Saadullah Khan
    Pharm-D, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
    (3) Syeda Komal Fatima
    Pharm-D, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
    (4) Amina Bibi
    Senior Chief Pharmacist, Federal Government Polyclinic Institute, Islamabad.
Fulltext PDF

References

  • Berger, R., Huelsman, M., Strecker, K., Bojic, A., Moser, P., Stanek, B., & Pacher, R. (2002). B- type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation, 105(20), 2392-2397.
  • Bonow, R. O. (1996). New insights into the cardiac natriuretic peptides. Circulation 1996; 93:1946-50.
  • Burke, M. A., Cotts, W. G. (2007). Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 2007;12:23-36.
  • Dao, Q. Krishnaswamy, P., Kazahegra, R., Harrison, A., Amirnovin, R., Lenert, L. et al. (2001). Utility of b-typenaturietic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-85
  • Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, JJ., Ponikowski, P., Poole-Wilson, P. A. et al. (2008). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442
  • El Mahmoud, R., Alibay, Y., Brun-Ney, D., Boulard, J. C., Dubourg, O. Puy H, et al. (2006). Type B natriuretic peptide (BNP) versus N-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population. Arch Mal Coeur Vaiss 2006;99:201-7.
  • Felker, G. M., Hasselblad, V., Hernandez, A. F., & O'Connor, C. M. (2009). Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. American heart journal, 158(3), 422-430.
  • Grewal, J., McKelvie, R., Lonn, E., Tait, P., Carlsson, J., Gianni, M., ... & Persson, H. (2008). BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. European journal of heart failure, 10(3), 252-259.
  • Hill, S. A., Balion C. M., Santaguida, P., McQueen, M. J., Ismaila, A. S., Reichert, S. M., et al. (2008). Evidence for the use of B-type natriuretic peptides for screening symptomatic populations and for diagnosis in primary care. Clin Biochem 2008;41:240-9
  • Januzzi, J. L., Camargo, C. A., Anwaruddin, S., Baggish, A. L., Chen, A. A., Krauser, D. G, et al. (2005). The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Am J Cardiol 2005;95:948-54.
  • Kagiyama, N., Kitai, T., Hayashida, A., Yamaguchi, T., Okumura, T., Kida, K., ... & Matsue, Y. (2019).Prognostic value of BNP reduction during hospitalization in patients with acute heart failure. Journal of cardiac failure, 25(9), 712- 721.
  • Mant, J., Al-Mohammad, A., Davis, M., Dawda, P., Gilmour, J., Hardman, S., et al. (2010). Chronic heart failure: NICE clinical guidelines for diagnosis and management in primary and secondary care. National Clinical Guideline Centre 2010.
  • Mant, J., Cowie, M. R., Doust, J., Roalfe, A., Barton, P., Glasziou, P., et al. (2009). Systemic review and individual patient data analysis of diagnosis of heart failure with modeling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009;13:13
  • McCullough, P. A., Nowak, R. M., McCord, J., Hollander, J. E., Herrmann, H. C., Steg, P. G., et al. (2002). B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-22
  • Nakagawa, O., Ogawa, Y., Itoh, H., Suga, S., Komatsu, Y., Kishimoto, I., et al. (1995). Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J ClinInvest 1995;96:1280-7.
  • Pfisterer, M., Buser, P., Rickli, H., Gutmann, M., Erne, P., Rickenbacher, P., ... & Time-CHF Investigators. (2009). BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. Jama, 301(4), 383-392.
  • O'Donoghue, M., Chen, A., Baggish, A. L., Anwaruddin, S., Krauser, D. G., Tung, R., et al. (2005). The effects of ejection fraction on N- terminal proBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Card Fail 2005;11:S9-14.
  • Porapakkham, P., Porapakkham, P. L., Zimmet, H., Billah, B., & Krum, H. (2009). BNP-Guided Heart Failure Therapy: A Meta-analysis of Randomized Control Trials. Heart, Lung and Circulation, 18, S171.
  • Schellenberger, U., O'Rear, J., Guzzetta, A., Jue, R. A., Protter, A. A., Pollitt, N. S., et al. (2006). The precursor to B-type natriuretic peptide is an O- linked glycoprotein. Arch Biochem Biophys 2006;451:160-6.
  • Sudoh, T., Kangawa, K., Minamino, N., Matsuo, H. (1988). A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
  • Uddin, M. H., Rashid, T., & Chowdhury, S. M. (2017). Role of B-type natriuretic peptide (BNP) in heart failure. International Journal on Disability and Human Development, 16(1), 3-9.
  • Wright, S. P., Doughty, R. N., Pearl, A., Gamble, G. D., Whalley, G. A., Walsh, H. J., et al. (2003). Plasma amino-terminal probrain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 2003;42:1793-800.
  • Zaphiriou, A., Robb, S., Murray-Thomas, T., Mendez, G., Fox, K., McDonagh, T., et al. (2005). The diagnostic accuracy of plasma BNP and NT proBNP in patients referred from primary care with suspected heart failure: results of the UK Natriuretic Peptide Study. Eur J Heart Fail 2005;7:537-41

Cite this article

APA

    APA : Shahid, A., Khan, M. S., & Fatima, S. K. (2019). Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF). Global Immunological & Infectious Diseases Review, IV(I), 10-16. https://doi.org/10.31703/giidr.2019(IV-I).02

CHICAGO

    CHICAGO : Shahid, Arooj, Muhammad Saadullah Khan, and Syeda Komal Fatima. 2019. "Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF)." Global Immunological & Infectious Diseases Review, IV (I): 10-16 doi: 10.31703/giidr.2019(IV-I).02

HARVARD

    HARVARD : SHAHID, A., KHAN, M. S. & FATIMA, S. K. 2019. Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF). Global Immunological & Infectious Diseases Review, IV, 10-16.

MHRA

    MHRA : Shahid, Arooj, Muhammad Saadullah Khan, and Syeda Komal Fatima. 2019. "Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF)." Global Immunological & Infectious Diseases Review, IV: 10-16

MLA

    MLA : Shahid, Arooj, Muhammad Saadullah Khan, and Syeda Komal Fatima. "Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF)." Global Immunological & Infectious Diseases Review, IV.I (2019): 10-16 Print.

OXFORD

    OXFORD : Shahid, Arooj, Khan, Muhammad Saadullah, and Fatima, Syeda Komal (2019), "Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF)", Global Immunological & Infectious Diseases Review, IV (I), 10-16

TURABIAN

    TURABIAN : Shahid, Arooj, Muhammad Saadullah Khan, and Syeda Komal Fatima. "Role of BNP and Pro-BNP as Prognostic Factors in Predicting the Mortality of Patients of Chronic Heart Failure (CHF)." Global Immunological & Infectious Diseases Review IV, no. I (2019): 10-16. https://doi.org/10.31703/giidr.2019(IV-I).02